- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Acute Myeloid Leukemia
Medical specialists from France tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 264 results
-
Lise WILLEMS, MDSeen in:
- Paris, Hôpital Cochin
- Paris, Hôpital Cochin APHP
Trials:- NCT04446962 (Principal Investigator)
- NCT02649790 (Principal Investigator)
Conditions:- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Acute Myeloid Leukemia (AML);
- Metastatic Colorectal Cancer (mCRC);
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Relapsed/Refractory Multiple Myeloma (RRMM);
- Higher-Risk Myelodysplastic Syndrome (HR-MDS);
- Newly Diagnosed Intermediate/High-Risk MDS
-
M. Hunault-BergerSeen in:
- Angers, FR-Angers-CHUANGERS
Trials:- NCT04027309 (Principal Investigator)
-
Madalina UzunovSeen in:
- Paris, Hopital de la Pitie Salpetriere
- Paris, Hôpital de la Pitié-Salpétrière
Trials:- NCT05260528 (Principal Investigator)
- NCT03439371 (Sub-Investigator)
Conditions: -
Maël HeibligSeen in:
- Lyon, Centre Hospitalier Lyon Sud
- Lyon, Hospices Civils de Lyon, Lyon-Sud Hospital
- Pierre Benite, Pierre-Bénite, CHU Lyon Sud
- Pierre-Benite, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Hopital Lyon Sud
Trials:- NCT04905407 (Principal Investigator)
- NCT04067336 (Principal Investigator)
- NCT04065399 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT04086264 (Principal Investigator)
- NCT03439371 (Sub-Investigator)
-
Marc BernardSeen in:
- Rennes, FR-Rennes cedex 9-CHURENNES
Trials:- NCT04027309 (Principal Investigator)
-
Maria-Pilar Gallego HernanzSeen in:
- Poitiers, FR-Poitiers-CHUPOITERS
Trials:- NCT04027309 (Principal Investigator)
-
Marie Adele DAMMACCOSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Marie Balsat, MDSeen in:
- Lyon, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Centre Hospitalier Lyon Sud, Hematology department
Trials:- NCT03439371 (Sub-Investigator)
- NCT03796533 (Sub-Investigator)
Conditions: -
Marie DetraitSeen in:
- Nancy, Centre Hospitalier Universitaire de Nancy
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Marie Lorrraine CHRETIEN, DrSeen in:
- Dijon, Dijon CHU
Trials:- NCT05070208 (Sub-Investigator)
Conditions: -
Marie Pierre Gourin, MDSeen in:
- Limoges, CHRU de Limoges
- Limoges, CHU Limoges
Trials:- NCT03503409 (Principal Investigator)
- NCT04905407 (Principal Investigator)
Conditions: -
Marie SEBERT, MDSeen in:
- Paris, Hôpital Saint Louis - Hématologie Séniors
Trials:- NCT03503409 (Principal Investigator)
Conditions: -
Marie Virginie Larcher, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud, Hematology department
Trials:- NCT03796533 (Sub-Investigator)
Conditions: -
Marie-Anne HOSPITAL, MDSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT04827719 (Principal Investigator)
Conditions: -
Marie-Thérèse RubioSeen in:
- Nancy, Centre Hospitalier Universitaire de Nancy
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Marie-Virginie Larcher, MDSeen in:
- Lyon, Centre Hospitalier Lyon Sud
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Mario Ojeda-UribeSeen in:
- Mulhouse, GHR Mulhouse Sud-Alsace
- Mulhouse, Groupe hospitalier de la région de Mulhouse et Sud-Alsace, Hôpital Emile Muller
- Mulhouse, Hôpital E. Muller-GHR Mulhouse Sud-Alsace
Trials:- NCT05260528 (Principal Investigator)
- NCT03503409 (Principal Investigator)
- NCT03744390 (Principal Investigator)
-
Marion Gillibert-Yvert, MDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
-
Martin CarréSeen in:
- Grenoble, Centre Hospitalier Universitaire de Grenoble
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Mathieu LECLERC, DrSeen in:
- Créteil, Henri Mondor Aphp
Trials:- NCT05070208 (Sub-Investigator)
Conditions: -
Matthieu CRETINONSeen in:
- Chambéry, Centre Hospitalier Metropole Savoie
Trials:- NCT03800095 (Sub-Investigator)
-
Maud D'AveniSeen in:
- Nancy, Centre Hospitalier Universitaire de Nancy
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Mauricette Michallet, MDSeen in:
- Lyon, Hôpital Edouard Herriot
- Pierre-Bénite, Centre Hospitalier Lyon Sud
Trials:- NCT03659084 (Principal Investigator)
- NCT00129155 (Principal Investigator)
-
Mehdi BRAHMISeen in:
- Lyon, Centre Leon Berard
Trials:- NCT05009927 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC;
- Malignant Solid Neoplasms
-
Mellie HEINEMANNSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Mélodie CARBONNAUXSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States